Physician

Kelly Lynn Harms, MD

According to 2025 Medicare claims, Kelly Harms, MD (NPI: 1174786693) practices micrographic dermatologic surgery in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1528097128; TIN: 386006309) and primary practice location at 48109-5000. Harms is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Harms' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 492 traditional Medicare patients, billed 1,305 HCPCS/CPT codes, and received $173,215 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 108 prescription claims across 82 beneficiaries totaling $1,119 in drug costs, led by Gentamicin Sulfate (Gentamicin Sulfate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $237,076 and ending at $173,215. Concurrently, Part D prescription costs have declined steadily, from $3,067 to $1,119. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$125K$251K2015 Medicare payment: $237,076 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $212,734 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $233,063 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $145,890 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $143,916 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $90,450 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $168,908 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $250,889 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $234,248 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $173,215 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155641,286$237,076
20165551,323$212,734
20176151,381$233,063
2018401998$145,890
2019398991$143,916
2020290714$90,450
20214121,206$168,908
20226651,847$250,889
20235951,699$234,248
20244921,305$173,215

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.7K$9.5K2015 Drug cost: $3,067 (USD; Tot_Drug_Cst)2016 Drug cost: $8,934 (USD; Tot_Drug_Cst)2017 Drug cost: $9,497 (USD; Tot_Drug_Cst)2018 Drug cost: $8,800 (USD; Tot_Drug_Cst)2019 Drug cost: $1,256 (USD; Tot_Drug_Cst)2020 Drug cost: $1,189 (USD; Tot_Drug_Cst)2021 Drug cost: $1,671 (USD; Tot_Drug_Cst)2022 Drug cost: $2,177 (USD; Tot_Drug_Cst)2023 Drug cost: $600 (USD; Tot_Drug_Cst)2024 Drug cost: $1,119 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015191231$3,067
2016170203$8,934
2017167209$9,497
2018103153$8,800
20197991$1,256
20207893$1,189
202197139$1,671
20228198$2,177
20236372$600
202482108$1,119

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks239291$236
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks106155$149
12032Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm5761$92
12052Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm5961$87
11102Biopsy of related skin growth, first growth6271$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gentamicin SulfateGentamicin Sulfate18429$557
Doxycycline HyclateDoxycycline Hyclate31307$179
MupirocinMupirocin19385$157
CephalexinCephalexin20110$70

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Kelly Lynn Harms, MD?

Tedicare shows public-source Medicare data for Kelly Lynn Harms, MD (NPI 1174786693), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kelly Lynn Harms, MD have ACO affiliation data?

Kelly Lynn Harms, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Kelly Lynn Harms, MD?

Kelly Lynn Harms, MD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1528097128) in the available physician profile data.

Does Kelly Lynn Harms, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.